The FDA has approved an antibiotic called minocycline for the treatment of rosacea in adults. The drug, which is taken orally ...

Combining medicated treatments with natural products is recommended, as botanical extracts offer more tolerable side effects. In the present review, researchers described the potential of ...

Rosacea is chronic and not curable, it is highly treatable and can be well-managed with over-the-counter products, treatments, medications or surgeries. It's important to speak with a ...

It should also be able to remove dirt, oil, and makeup without stripping the skin of its natural oils, which can lead to dryness and irritation. When choosing a cleanser for rosacea, it’s ...

Topical treatments for both acne and rosacea that contain benzoyl peroxide (BPO) can degrade into the known carcinogen benzene if they are stored at room temperature or higher. Exposure to ultraviolet ...

Side effects of doxycycline include the following: It's important to know that rosacea is a chronic condition with no cure.

So, to help dispel some myths and to find out what ingredients and professional treatments exist that can help manage and lessen rosacea symptoms, we spoke to Dr Emma Craythorne, consultant ...

While there are plenty of over-the-counter treatments and products that can help alleviate the symptoms of rosacea, a dermatologist may be able to offer more intensive treatments. "[T]here are ...

Short articles that focus on some of the key challenges, issues or developments in natural products research. They can be "opinion" style articles, which give the author's perspective on a particular ...

Nature Portfolio is here to serve the research community by publishing its most significant discoveries—findings that advance knowledge and address some of the greatest challenges that we face ...

Please read this section before submitting anything to Nature. This section explains Nature's editorial criteria, and how manuscripts are handled by our editors between submission and acceptance ...

Fortress Biotech, Inc. (NASDAQ: FBIO) announced through its majority-controlled subsidiary, Journey Medical Corporation, that the U.S. Food and Drug Administration (FDA) has approved Emrosi™ ...